Your patients’ health is your top priority. Better understand your patient’s genes and how they may impact their medications. Genelex, a leader in the field of molecular diagnostics and genetics laboratory testing for more than 30 years, in conjunction with a leading clinical decision support tool (CDST), may help you bring more effective medication management especially for high risk polypharmacy patients. The CDST was inspired by a healthcare provider who wanted to establish a more automated and precise medication management system to enhance patient care.

Genelex is a leader in precision medication management. A pioneer in DNA testing since 1987, Genelex now focuses exclusively on pharmacogenetic testing. Backed by a powerful combination of innovative analytics software, state-of art laboratory facilities, and expert staff, Genelex has a longstanding commitment to the prevention of dangerous and life-threatening adverse drug events (ADEs).